Fragment-Based Screening Using Surface Plasmon Resonance Technology

被引:85
作者
Perspicace, Samantha [1 ]
Banner, David [1 ]
Benz, Joerg [1 ]
Mueller, Francis [1 ]
Schlatter, Daniel [1 ]
Huber, Walter [1 ]
机构
[1] F Hoffmann La Roche & Co Ltd, Pharma Res, Discovery Technol, Basel, Switzerland
关键词
affinity; binding; selectivity; competition; high-throughput screening (HTS); surface plasmon resonance (SPR); GUIDED OPTIMIZATION; LIGAND INTERACTIONS; DRUG DISCOVERY; LEAD DISCOVERY; INHIBITORS; FLUORESCENCE; VALIDATION; GENERATION; CHEMISTRY; DNA;
D O I
10.1177/1087057109332595
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
Surface plasmon resonance (SPR) technology has emerged as a new and powerful technique to investigate the interaction between low-molecular-weight molecules and target proteins. In the present work, the authors assemble from a large compound collection a library of 2226 molecules (fragments having low molecular weights between 100 and 300 Da) to screen them for binding to chymase, a serine protease. Both the active chymase and a zymogen-like form of the protein were used in parallel to distinguish between specific and unspecific binding. The relative ligand-binding activity of the immobilized protein was periodically measured with a reference compound. The screening experiments were performed at 25 C at a fragment concentration of 200 mu M in the presence of 2% DMSO. Applying the filter cascade, affinity-selectivity-competition (competition with reference compounds and cross-competition with fragments), 80 compounds show up as positive screening hits. Competition experiments between fragments show that they bind to different parts of the active site. Of 36 fragments co-crystallized for X-ray studies, 12 could be located in the active site of the protein. These results validate the authors' library and demonstrate that the application of SPR technology as a filter in fragment screening can be achieved successfully. (Journal of Biomolecular Screening. 2009:337-349)
引用
收藏
页码:337 / 349
页数:13
相关论文
共 26 条
[1]   An integrated approach to fragment-based lead generation: Philosophy, strategy and case studies from AstraZeneca's drug discovery programmes [J].
Albert, Jeffrey S. ;
Blomberg, Niklas ;
Breeze, Alexander L. ;
Brown, Alastair J. H. ;
Burrows, Jeremy N. ;
Edwards, Philip D. ;
Folmer, Rutger H. A. ;
Geschwindner, Stefan ;
Griffen, Ed J. ;
Kenny, Peter W. ;
Nowak, Thorsten ;
Olsson, Lise-Lotte ;
Sanganee, Hitesh ;
Shapiro, Adam B. .
CURRENT TOPICS IN MEDICINAL CHEMISTRY, 2007, 7 (16) :1600-1629
[2]   CORRECTION FOR LIGHT-ABSORPTION IN FLUORESCENCE STUDIES OF PROTEIN-LIGAND INTERACTIONS [J].
BIRDSALL, B ;
KING, RW ;
WHEELER, MR ;
LEWIS, CA ;
GOODE, SR ;
DUNLAP, RB ;
ROBERTS, GCK .
ANALYTICAL BIOCHEMISTRY, 1983, 132 (02) :353-361
[3]   Novel inhibitors of DNA gyrase: 3D structure based biased needle screening, hit validation by biophysical methods, and 3D guided optimization. A promising alternative to random screening [J].
Boehm, HJ ;
Boehringer, M ;
Bur, D ;
Gmuender, H ;
Huber, W ;
Klaus, W ;
Kostrewa, D ;
Kuehne, H ;
Luebbers, T ;
Meunier-Keller, N .
JOURNAL OF MEDICINAL CHEMISTRY, 2000, 43 (14) :2664-2674
[4]  
Bohacek RS, 1996, MED RES REV, V16, P3, DOI 10.1002/(SICI)1098-1128(199601)16:1<3::AID-MED1>3.3.CO
[5]  
2-D
[6]   A rule of three for fragment-based lead discovery? [J].
Congreve, M ;
Carr, R ;
Murray, C ;
Jhoti, H .
DRUG DISCOVERY TODAY, 2003, 8 (19) :876-877
[7]  
Eftink MR, 1997, METHOD ENZYMOL, V278, P221
[8]   In situ assembly of enzyme inhibitors using extended tethering [J].
Erlanson, DA ;
Lam, JW ;
Wiesmann, C ;
Luong, TN ;
Simmons, RL ;
DeLano, WL ;
Choong, IC ;
Burdett, MT ;
Flanagan, WM ;
Lee, D ;
Gordon, EM ;
O'Brien, T .
NATURE BIOTECHNOLOGY, 2003, 21 (03) :308-314
[9]   High throughput screening: Early successes indicate a promising future [J].
Fox, S ;
Wang, H ;
Sopchak, L ;
Khoury, R .
JOURNAL OF BIOMOLECULAR SCREENING, 2001, 6 (03) :137-140
[10]   Surface plasmon resonance based assay for the detection and characterization of promiscuous inhibitors [J].
Giannetti, Anthony M. ;
Koch, Bruce D. ;
Browner, Michelle F. .
JOURNAL OF MEDICINAL CHEMISTRY, 2008, 51 (03) :574-580